Money Talks: Why Illumina Ventures’ Wouter Meuleman is hyped about Covid

About a third of the Foster City-based venture firm's portfolio of companies is working in the Covid-19 space. "Genomics is a great enabler of biomedical research," Meuleman says.

Click to view original post